Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IPM-N001 is a bivalent, bimodal radiopharmaceutical precursor designed for targeting carbonic anhydrase IX (CAIX) and tumor hypoxia. Developed by researchers at the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, IPM-N001 was created by conjugating a hypoxia-sensitive 2-nitroimidazole (NI) moiety to the cyclic peptide DPI-4452 scaffold. When radiolabeled with gallium-68 to form [68Ga]Ga-IPM-N001, it serves as a PET/CT imaging radiotracer. In preclinical models of clear cell renal cell carcinoma (ccRCC), [68Ga]Ga-IPM-N001 demonstrated significantly enhanced tumor accumulation and superior tumor-to-background ratios compared to [68Ga]Ga-DPI-4452, without increasing physiological uptake in normal organs like the stomach and kidneys.
| Indication | Highest phase | Status |
|---|---|---|
| clear-cell renal cell carcinoma (ccRCC) | Preclinical | Active |
Every indication, with countries and timelines, is in the full profile.
| Market | Status | Year |
|---|---|---|
| United States | Not approved | — |
| European Union | Not approved | — |
| China | Not approved | — |
| Japan | Not approved | — |
Approved indications and other markets are in the full profile.
Lead indication: clear-cell renal cell carcinoma (ccRCC)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on IPM-N001.
Work on IPM-N001? Claim this page to correct or add information. Claim this page